The attorneys of Morris James’ Intellectual Property Practice command respect as established and dominant leaders in Delaware in the arena of intellectual property strategy, management, enforcement, and defense. Our status has been earned as a result of decades of trials, representing Fortune 500 companies across the nation. Our attorneys are recognized for excellence in intellectual property law by organizations that include only attorneys of the highest caliber, including Chambers USA – America’s Leading Lawyers for Business, Best Lawyers®, Benchmark Litigation: The Definitive Guide to America’s Leading Firms and Attorneys, and Delaware Super Lawyers®.
We actively practice patent litigation in the United States District Court for the District of Delaware, and represent clients in a broad range of intellectual property disputes across numerous industries, including pharmaceuticals, telecommunications, automotive, biomedical, electronics, internet, and software development, among others. Our attorneys regularly act as counsel in national intellectual property litigation concerning patents, copyrights, trade secret, trademarks, and antitrust dispute cases.
Our attorneys are leaders in Delaware’s Courts, as well as professional and educational groups. We know the law, the Courts, the judges, and the mediators. The practice chair for the Intellectual Property Practice is Kenneth Dorsney. Mr. Dorsney has spoken at numerous seminars and law schools on patent law and litigation and is Editor-in-Chief and a Co-Author of ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators and Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio.
- August 15, 2018
- Chambers USA: America's Leading Lawyers for Business Recognizes 15 Morris James Lawyers and Issues 5 Firm Practice Rankings in the 2018 EditionMay 7, 2018Chambers USA, 2018 Edition
- November 1, 2017
- September 29, 2017
- August 15, 2017
- May 26, 2017Chambers USA
- November 4, 2016
- October 24, 2016
- Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Second EditionAugust 1, 2018
- Kenneth L. Dorsney Is Editor-In-Chief and Co-Author of a Second Edition of Premier ANDA Litigation BookJune 2016
- November 5, 2014
- August 27, 2014
- Kenneth L. Dorsney Is Editor-In-Chief and a Co-Author of a New ANDA Litigation Book Published by the American Bar AssociationMay 2012
- The Patent PowerhouseMay 2010